Other
Drug Facts
The following Structured Product Label (SPL) was submitted to the FDA by Cardinal Health 107, Llc for the product Miralax (NDC 55154-5035). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding other, active ingredient (in each dose) (bottle only), purpose, active ingredient (in each dose) (packet only), use, allergy alert, otc - do not use, ask a doctor before use if you have, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Drug Facts
Polyethylene Glycol 3350, 17 g (cap filled to line)
Osmotic Laxative
Osmotic Laxative
Polyethylene Glycol 3350, 17 g
Do not use if you are allergic to polyethylene glycol
Do not use if you have kidney disease, except under the advice and supervision of a doctor
Ask a doctor of pharmacist before use if you are taking a prescription drug
When using this product you may have loose, watery, more frequent stools
If pregnant or breast-feeding, ask a health professional before use.
Keep out of the reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.
none
1-800-MiraLAX (1-800-647-2529)
Overbagged with 6 x 17g packets per bag, NDC 55154-5035-6
WARNING: This Unit Dose package is not child resistant and is Intended for Institutional Use Only. Keep this and all drugs out of the reach of children.
Distributed By:
Cardinal Health
Dublin, OH 43017
L4532222-11025 / L4532222-21025
* Please review the disclaimer below.